Nanofibres in Drug Delivery / / Gareth R. Williams, Bahijja T. Raimi-Abraham, C. J. Luo.

In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
TeilnehmendeR:
Place / Publishing House:London, England : : UCL Press,, 2018.
Year of Publication:2018
Language:English
Physical Description:1 online resource (242 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603479604498
ctrlnum (CKB)5580000000527185
(NjHacI)995580000000527185
(EXLCZ)995580000000527185
collection bib_alma
record_format marc
spelling Williams, Gareth R., author.
Nanofibres in Drug Delivery / Gareth R. Williams, Bahijja T. Raimi-Abraham, C. J. Luo.
London, England : UCL Press, 2018.
1 online resource (242 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres in the laboratory. The book begins with a brief discussion of the main concepts in pharmaceutical science. The authors then introduce the key techniques that can be used for fibre production and explain briefly the theory behind them. They discuss the experimental implementation of fibre production, starting with the simplest possible set-up and then moving on to consider more complex arrangements. As they do so, they offer advice from their own experience of fibre production, and use examples from current literature to show how each particular type of fibre can be applied to drug delivery. They also consider how fibre production could be moved beyond the research laboratory into industry, discussing regulatory and scale-up aspects.
Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References.
Drug delivery systems.
1-78735-021-5
Luo, C. J., author.
Raimi-Abraham, Bahijja T., author.
language English
format eBook
author Williams, Gareth R.,
Luo, C. J.,
Raimi-Abraham, Bahijja T.,
spellingShingle Williams, Gareth R.,
Luo, C. J.,
Raimi-Abraham, Bahijja T.,
Nanofibres in Drug Delivery /
Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References.
author_facet Williams, Gareth R.,
Luo, C. J.,
Raimi-Abraham, Bahijja T.,
Luo, C. J.,
Raimi-Abraham, Bahijja T.,
author_variant g r w gr grw
c j l cj cjl
b t r a btr btra
author_role VerfasserIn
VerfasserIn
VerfasserIn
author2 Luo, C. J.,
Raimi-Abraham, Bahijja T.,
author2_role TeilnehmendeR
TeilnehmendeR
author_sort Williams, Gareth R.,
title Nanofibres in Drug Delivery /
title_full Nanofibres in Drug Delivery / Gareth R. Williams, Bahijja T. Raimi-Abraham, C. J. Luo.
title_fullStr Nanofibres in Drug Delivery / Gareth R. Williams, Bahijja T. Raimi-Abraham, C. J. Luo.
title_full_unstemmed Nanofibres in Drug Delivery / Gareth R. Williams, Bahijja T. Raimi-Abraham, C. J. Luo.
title_auth Nanofibres in Drug Delivery /
title_new Nanofibres in Drug Delivery /
title_sort nanofibres in drug delivery /
publisher UCL Press,
publishDate 2018
physical 1 online resource (242 pages)
contents Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References.
isbn 1-78735-021-5
callnumber-first R - Medicine
callnumber-subject RS - Pharmacy
callnumber-label RS199
callnumber-sort RS 3199.5 W555 42018
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 615 - Pharmacology & therapeutics
dewey-full 615.6
dewey-sort 3615.6
dewey-raw 615.6
dewey-search 615.6
work_keys_str_mv AT williamsgarethr nanofibresindrugdelivery
AT luocj nanofibresindrugdelivery
AT raimiabrahambahijjat nanofibresindrugdelivery
status_str n
ids_txt_mv (CKB)5580000000527185
(NjHacI)995580000000527185
(EXLCZ)995580000000527185
carrierType_str_mv cr
is_hierarchy_title Nanofibres in Drug Delivery /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1787553588116979712
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04983nam a2200313 4500</leader><controlfield tag="001">993603479604498</controlfield><controlfield tag="005">20230517153048.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230517s2018 enk o u000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5580000000527185</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995580000000527185</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995580000000527185</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS199.5</subfield><subfield code="b">.W555 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Williams, Gareth R.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanofibres in Drug Delivery /</subfield><subfield code="c">Gareth R. Williams, Bahijja T. Raimi-Abraham, C. J. Luo.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, England :</subfield><subfield code="b">UCL Press,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (242 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres in the laboratory. The book begins with a brief discussion of the main concepts in pharmaceutical science. The authors then introduce the key techniques that can be used for fibre production and explain briefly the theory behind them. They discuss the experimental implementation of fibre production, starting with the simplest possible set-up and then moving on to consider more complex arrangements. As they do so, they offer advice from their own experience of fibre production, and use examples from current literature to show how each particular type of fibre can be applied to drug delivery. They also consider how fibre production could be moved beyond the research laboratory into industry, discussing regulatory and scale-up aspects.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug delivery systems.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78735-021-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luo, C. J.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raimi-Abraham, Bahijja T.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-06-09 11:00:35 Europe/Vienna</subfield><subfield code="f">System</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-04-02 14:12:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337614250004498&amp;Force_direct=true</subfield><subfield code="Z">5337614250004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337614250004498</subfield></datafield></record></collection>